These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20458678)

  • 21. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.
    Klein DJ; Cottingham EM; Sorter M; Barton BA; Morrison JA
    Am J Psychiatry; 2006 Dec; 163(12):2072-9. PubMed ID: 17151157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of diabetes in children and adolescents exposed to antipsychotics: a nationwide 12-year case-control study.
    Nielsen RE; Laursen MF; Vernal DL; Bisgaard C; Jakobsen H; Steinhausen HC; Correll CU
    J Am Acad Child Adolesc Psychiatry; 2014 Sep; 53(9):971-979.e6. PubMed ID: 25151420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A regional comparison of developing diabetes among VA patients exposed to typical and atypical antipsychotics relative to corticosteroids and proton pump inhibitors.
    Barnett M; Argo T; Alexander B; Perry P
    Ann Clin Psychiatry; 2006; 18(1):1-7. PubMed ID: 16517447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of olanzapine and risperidone on metabolic factors in children and adolescents: a retrospective evaluation.
    Khan RA; Mican LM; Suehs BT
    J Psychiatr Pract; 2009 Jul; 15(4):320-8. PubMed ID: 19625888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
    Stahl SM; Mignon L; Meyer JM
    Acta Psychiatr Scand; 2009 Mar; 119(3):171-9. PubMed ID: 19178394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The implications of weight changes with antipsychotic treatment.
    Sussman N
    J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S21-6. PubMed ID: 12832946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.
    Newcomer JW
    J Clin Psychiatry; 2004; 65 Suppl 18():36-46. PubMed ID: 15600383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses.
    Moreno C; Merchán-Naranjo J; Alvarez M; Baeza I; Alda JA; Martínez-Cantarero C; Parellada M; Sánchez B; de la Serna E; Giráldez M; Arango C
    Bipolar Disord; 2010 Mar; 12(2):172-84. PubMed ID: 20402710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management.
    Stigler KA; Potenza MN; Posey DJ; McDougle CJ
    Paediatr Drugs; 2004; 6(1):33-44. PubMed ID: 14969568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic syndrome with the atypical antipsychotics.
    Pramyothin P; Khaodhiar L
    Curr Opin Endocrinol Diabetes Obes; 2010 Oct; 17(5):460-6. PubMed ID: 20717020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type 2 diabetes in children and adolescents on atypical antipsychotics.
    Pramyothin P; Khaodhiar L
    Curr Diab Rep; 2015 Aug; 15(8):53. PubMed ID: 26084582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Herbal Therapies for Weight Gain and Metabolic Abnormalities Induced by Atypical Antipsychotics: A Review Article.
    Naghibi H; Salari R; Yousefi M; Khadem-Rezaiyan M; Ghanbarzadeh MR; Fayyazi Bordbar MR
    Curr Drug Discov Technol; 2023; 20(5):e110423215660. PubMed ID: 37055899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of treatment-emergent diabetes mellitus in patients receiving antipsychotics.
    Citrome LL; Holt RI; Zachry WM; Clewell JD; Orth PA; Karagianis JL; Hoffmann VP
    Ann Pharmacother; 2007 Oct; 41(10):1593-603. PubMed ID: 17785613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical antipsychotic drugs, schizophrenia, and metabolic syndrome in non-Euro-American societies.
    Bou Khalil R
    Clin Neuropharmacol; 2012; 35(3):141-7. PubMed ID: 22592510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The metabolic syndrome in an Italian psychiatric sample: a retrospective chart review of inpatients treated with antipsychotics.
    Santini I; Stratta P; D'Onofrio S; De Lauretis I; Santarelli V; Pacitti F; Rossi A
    Riv Psichiatr; 2016; 51(1):37-42. PubMed ID: 27030348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms in endocrinology: Antipsychotic medication and type 2 diabetes and impaired glucose regulation.
    Whicher CA; Price HC; Holt RIG
    Eur J Endocrinol; 2018 Jun; 178(6):R245-R258. PubMed ID: 29559497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse events in children and adolescents treated with antipsychotic medications.
    Jerrell JM; McIntyre RS
    Hum Psychopharmacol; 2008 Jun; 23(4):283-90. PubMed ID: 18302312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Metabolic syndrome in patients with schizophrenia independently from atypical antipsychotics intake].
    Bou Khalil R
    Presse Med; 2012 May; 41(5):e238-43. PubMed ID: 22154487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of patients' preexisting metabolic risk factors on the choice of antipsychotics by office-based physicians.
    Li C; Mittal D; Owen RR
    Psychiatr Serv; 2011 Dec; 62(12):1477-84. PubMed ID: 22193796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular study of weight gain related to atypical antipsychotics: clinical implications of the CYP2D6 genotype.
    Nussbaum LA; Dumitraşcu V; Tudor A; Grădinaru R; Andreescu N; Puiu M
    Rom J Morphol Embryol; 2014; 55(3):877-84. PubMed ID: 25329115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.